Vebreltinib for Advanced Non–Small Cell Lung Cancer Harboring c-Met Exon 14 Skipping Mutation: A Multicenter, Single-Arm, Phase II KUNPENG Study Although not the primary study intent, this dataset ...

The current standard of care for treating patients with stage 3 colon cancer is to use adjuvant therapy with FOLFOX, a combination of the drugs fluorouracil, leucovorin, and oxaliplatin. Although ...

Recently, shortening the duration of oxaliplatin-based adjuvant therapy, according to the IDEA collaboration, has led to similar outcomes with an improved burden of toxicity. In a pooled analysis of ...

January 27, 2012 (San Francisco, California) — Adjuvant therapy with capecitabine plus oxaliplatin (XELOX) significantly improves overall survival, compared with ...

In this study, we investigated the kinetics of oxaliplatin-DNA adduct formation in white blood cells of cancer patients in relation to efficacy as well as oxaliplatin-associated neurotoxicity.

When the discriminative and calibration ability was given priority, the ANN model outperformed the LR model in predicting the risk of OILI. Other chemotherapy drugs in oxaliplatin-based chemotherapy ...

The FDA issued a complete response letter for glofitamab-gxbm plus gemcitabine and oxaliplatin (GemOx) in relapsed/refractory diffuse large B-cell lymphoma (DLBCL), citing insufficient STARGLO trial ...

Does oxaliplatin benefit come with an age limit in patients with stage II or III colorectal cancer (CRC)? New data from a population-based cohort showed that adding oxaliplatin chemotherapy to ...

Please provide your email address to receive an email when new articles are posted on . An oral cryotherapy intervention that involved ice chips appeared to reduce oxaliplatin-induced oral symptoms ...

Oxaliplatin and 5-fluorouracil (5-FU) combination is a standard treatment for metastatic colorectal cancer. It is generally well tolerated but neurotoxicity thought to be caused by oxalate, a ...